Wednesday, July 23, 2014
The new Biomet NANO stemless total shoulder, co-designed by Dr. Bailie, has been off to a fast start in Europe. Hundreds have been used for both primary and reverse should replacement with many European surgeon users raving about the simplicity and the ability to customize the device intra-operatively. In addition, the IRB/FDA approved clinical trial has started in the US at 12 centers, of which Dr. Bailie is one (the only center in the Western half of the US). He has enrolled and completed surgeries on qualified patients and will continue to enroll patients who qualify until he reaches the maximum allowed by the FDA. Great job Dr. Bailie!